Omada Health, Inc. (NASDAQ:OMDA) Receives $22.91 Average PT from Analysts

Shares of Omada Health, Inc. (NASDAQ:OMDA) have been given an average rating of “Moderate Buy” by the thirteen analysts that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $22.9091.

A number of brokerages have recently issued reports on OMDA. Canaccord Genuity Group set a $24.00 price target on shares of Omada Health in a research note on Friday, May 8th. JPMorgan Chase & Co. lowered their target price on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Needham & Company LLC restated a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. BMO Capital Markets lowered their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a research report on Thursday, June 4th.

Insider Activity at Omada Health

In other Omada Health news, President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $17.24, for a total transaction of $79,114.36. Following the transaction, the president directly owned 316,238 shares in the company, valued at approximately $5,451,943.12. This represents a 1.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Craig Gracey sold 6,894 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48. Following the transaction, the chief accounting officer owned 9,191 shares in the company, valued at $160,107.22. The trade was a 42.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 36,072 shares of company stock valued at $612,034. 6.38% of the stock is owned by corporate insiders.

Institutional Trading of Omada Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Bank of America Corp DE lifted its holdings in shares of Omada Health by 51.5% in the first quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock valued at $2,025,000 after purchasing an additional 54,792 shares in the last quarter. Stoic Point Capital Management LLC purchased a new stake in shares of Omada Health in the first quarter valued at about $1,830,000. Quantinno Capital Management LP lifted its holdings in shares of Omada Health by 464.1% in the first quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock valued at $738,000 after purchasing an additional 48,313 shares in the last quarter. Entropy Technologies LP purchased a new stake in shares of Omada Health in the first quarter valued at about $194,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Omada Health by 173.9% in the first quarter. Renaissance Technologies LLC now owns 391,069 shares of the company’s stock valued at $4,916,000 after purchasing an additional 248,269 shares in the last quarter.

Omada Health Price Performance

Shares of Omada Health stock opened at $17.64 on Tuesday. Omada Health has a 52-week low of $10.28 and a 52-week high of $26.92. The company’s 50-day simple moving average is $15.84 and its 200-day simple moving average is $14.80. The firm has a market cap of $1.05 billion and a price-to-earnings ratio of -65.33.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The business had revenue of $78.05 million for the quarter. Equities research analysts anticipate that Omada Health will post -0.01 EPS for the current year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.